Laboratory Records
PEPTIDES BIO / MATERIAL RECORD
CJC-1295 (No DAC) / Ipamorelin Blend (5mg / 5mg)
Research-use peptide material record: pack format, specifications and COA/SDS request for qualified laboratory review.
RESEARCH USE ONLYRUO
CJC-1295 (No DAC) / Ipamorelin Blend (5mg / 5mg)
Important NoticeThis product is for use only in vitro research. It is strictly prohibited for human injection, clinical treatment, food addition or any animal experiments. Please read our terms and conditions carefully before placing an order.
Volume pricing
Configured totals update at each quantity threshold.
Configured total$33.29
Request COA / MSDS
Research record
Pending manual confirmationResearch overview
The combination of CJC‑1295 (without DAC) and Ipamorelin is currently recognized as the gold‑standard protocol for growth hormone secretagogues in peptide research. The two agents act synergistically to mimic the natural secretion rhythm of human growth hormone (GH). CJC‑1295 (without DAC), also known as modified GRF(1–29), is a growth hormone‑releasing hormone (GHRH) analogue. It stimulates the synthesis and release of endogenous GH by activating GHRH receptors in the anterior pituitary gland. Its structure incorporates four key amino acid substitutions that enhance enzymatic stability, conferring a half‑life of approximately 30 minutes and enabling a near‑physiological pulsatile GH secretion pattern. Ipamorelin is a synthetic pentapeptide (5 amino acids) belonging to the third generation of growth hormone‑releasing peptides (GHRPs). As a highly selective GHS‑R agonist, it induces GH release by mimicking the activity of ghrelin. A key advantage over earlier GHRP compounds is that Ipamorelin effectively promotes GH secretion without significantly affecting cortisol or prolactin levels. When used in combination, CJC‑1295 (without DAC) potentiates GHRH signaling, while Ipamorelin serves as a GHS‑mediated trigger for GH release, together generating a coordinated pulse that mirrors the natural GH rhythm. Research has confirmed that this combination stimulates physiological pulsatile GH release, supporting processes such as muscle development, lipid metabolism, tissue repair, and restorative sleep.
Research reference
Product FAQ
What is the CJC-1295 (No DAC) / Ipamorelin Blend?
The CJC-1295 (No DAC) / Ipamorelin Blend is a combination formulation of two synergistic peptides: CJC-1295 (No DAC), a GHRH agonist that stimulates the pituitary gland to release growth hormone, and Ipamorelin, a GHRP that amplifies GH pulses. Together, they produce a synergistic effect—CJC-1295 provides baseline stimulation while Ipamorelin enhances pulse amplitude, achieving a more physiological GH release pattern.
What is the mechanism of action of the CJC-1295 (No DAC) / Ipamorelin Blend?
Together, they produce a stronger GH release effect than either peptide alone, while maintaining a natural pulsatile GH secretion pattern due to their short half-lives (~30 minutes for CJC-1295, ~2 hours for Ipamorelin).
What are the advantages of the CJC-1295 (No DAC) / Ipamorelin Blend over using each peptide separately?
Advantages of the blend include:
· Synergistic effect: Dual-pathway stimulation produces stronger GH release
· More physiological pattern: Short half-lives maintain natural pulsatile release
· Dosing convenience: Single injection delivers both peptides without separate injections
· Dose optimization: Allows lower doses to achieve comparable effects
· Cost-effectiveness: Blends are typically more cost-effective than purchasing two separate peptides
Does the CJC-1295 (No DAC) / Ipamorelin Blend have research value for muscle repair and regeneration?
Yes. The GH/IGF-1 axis plays a critical role in muscle protein synthesis and satellite cell activation. Studies suggest that this blend can accelerate muscle injury repair by promoting myosatellite cell proliferation, increasing collagen synthesis, and reducing muscle breakdown, making it a subject of great interest in sports medicine and musculoskeletal injury research.
What are the main research areas for the CJC-1295 (No DAC) / Ipamorelin Blend?
· Growth hormone deficiency
· Muscle growth and strength enhancement
· Fat metabolism and weight loss
· Anti-aging research
· Sleep quality improvement
· Tissue repair and regeneration
· Bone density enhancement
Data sheet
Manual confirmation- Material Type
- Blend
- Purity Identity
- ≥99% purity
- Molecular Weight
- 3367.9 g/mol/711.85 g/mol
- Pack Size
- 5mg / 5mg
- Molecular Formula
- C512H252N44O42/C38H49N9O5
- CAS Number
- 863288-34-0/170851-70-4
- PubChem CID
- 56841945/9831659
- Storage conditions overview
- Storage typeLong-termTemperature-80°CDuration2-3 yearsNotesSealed, dark, minimal openingStorage typeStandardTemperature-20°CDuration1-2 yearsNotesSealed, dark, moisture-proofStorage typeShort-termTemperature4°CDuration1-2 weeksNotesTemporary storage, use promptlyStorage typeWorking SolutionTemperature4°CDuration1-7 daysNotesReconstituted, short-term, avoid freeze-thaw